Expand your network before, during, and after the 2017 Genitourinary Cancers Symposium. Connect with colleagues onsite or via one of the professional networking portals below.
Tweeting about the 2017 GU Cancers Symposium? Use the official Symposium hashtag #GU17.
Connect with colleagues on Twitter
Follow the #GU17 Featured Voices for expert insights and live updates from the meeting.
View Featured Voices' disclosure information below.
Start a discussion on LinkedIn
Share your experience on Facebook
Discover more on YouTube
Featured Voices Disclosures
All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Research Funding - amgen (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); ImClone Systems (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Rexahn Pharmaceuticals (Inst); Takeda (Inst); TRACON Pharma (Inst)
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Foundation Medicine; GlaxoSmithKline; Merck; Novartis; Pfizer; Prometheus; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)
No Relationships to Disclose
James L. Gulley
Consulting or Advisory Role - TRM Oncology
Sumanta K. Pal
Honoraria - Astellas Pharma; Medivation; Novartis
Consulting or Advisory Role - Aveo; Bristol-Myers Squibb; Exelixis; Genentech; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation
Consulting or Advisory Role - Acceleron Pharma; AstraZeneca/MedImmune; Bristol-Myers Squibb ; Genentech/Roche; Lilly; Novartis; Pfizer; Synergene
Research Funding - Acceleron Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - U.S. Patent No.: 14/588,503, Filed 1/2/2015. (Inst)